David Iklé (Ph.D., Senior Statistical Scientist) is the Principal Investigator for the iWITH coordinating center. Rho is also currently working with this same research team to develop another study evaluating the feasibility and safety of using donor-reactive regulatory T cell therapy to facilitate immunosuppression withdrawal in pediatric liver transplant recipients.